Aoife Murphy

Mr Marino — who will not be based in Dublin — brings with him an intimate knowledge of EU pharmaceutical law and familiarity of Union practice and procedures gained over his 25 years with industry and nearly 11 years with the EMA.

His responsibilities at the EMA included providing legal advice to the agency’s management, overseeing the legal department and providing support to core business colleagues on pharmaceutical law and regulatory matters, supervising its litigation strategy in the EU courts, and regularly interacting with other agencies’ legal experts on personal data protection, insurance matters and artificial intelligence.

Prior to joining EMA, Mr Marino held the position of general counsel of the Menarini Group for eight years, then GC at Sigma-Tau (now Alfasigma) for 15 years, in addition to nearly two more years in the petrochemical sector.

He also chaired EFPIA’s trademark group for eight years and was a member of that association’s intellectual property policy committee for 15 years.

Commenting on the appointment, Aoife Murphy, partner at DLA Piper Ireland, said: “Ireland is home to all but one of the world’s 25 largest biotech and pharma companies so the appointment of Stefano to the firm as senior consultant is significant.

“The knowledge, prestige and recognition that Stefano possesses in the European and international life sciences market will undoubtedly enhance our ability to solve complex regulatory challenges for our clients, not only corporates, but also industry associations and regulatory authorities as they seek counsel on the changing regulatory framework governing medicinal products in the EU.

“As part of our ambition to establish a leading life sciences regulatory practice in the EU and globally, his appointment provides a major boost.”